BrainsWay (BrainsWay) Other Stockholders Equity : $4.56 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is BrainsWay Other Stockholders Equity?

BrainsWay's Other Stockholders Equity for the quarter that ended in Mar. 2024 was $4.56 Mil.

BrainsWay's quarterly Other Stockholders Equity increased from Sep. 2023 ($3.52 Mil) to Dec. 2023 ($4.36 Mil) and increased from Dec. 2023 ($4.36 Mil) to Mar. 2024 ($4.56 Mil).

BrainsWay's annual Other Stockholders Equity increased from Dec. 2021 ($5.34 Mil) to Dec. 2022 ($6.18 Mil) but then declined from Dec. 2022 ($6.18 Mil) to Dec. 2023 ($4.36 Mil).

BrainsWay Other Stockholders Equity Historical Data

The historical data trend for BrainsWay's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BrainsWay Other Stockholders Equity Chart

BrainsWay Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

4.44

5.34

6.18

4.36

BrainsWay Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Stockholders Equity	Get a 7-Day Free Trial															6.13	3.83	3.52	4.36	4.56

BrainsWay Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

BrainsWay Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of BrainsWay's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BrainsWay (BrainsWay) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BrainsWay Ltd (OTCPK:BRSYF) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

BWAY:USA BWAY:Israel

Address

19 Hartum Street, 3rd Floor, Bynet Building, Har Hotzvim, Jerusalem, ISR, 9777518

Website

https://www.brainsway.com

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.